Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Volckmann

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cancer Letters|October 10, 2009
MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3Ingrid Revet, Gerda Huizenga, Jan Koster, et al.
Journal of Medical Virology|April 9, 2026
Temporal Nasal Epithelial Gene Expression Patterns in Healthy Individuals Infected With Rhinovirus-16, and Its Modulation by Carrot Rhamnogalacturonan-IJasper Mol, Richard Volckmann, Abilash Ravi, et al.
International Journal of Molecular Sciences|April 13, 2023
Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva OsteoclastsTon Schoenmaker, Joy Zwaak, Bruno G Loos, et al.
Experimental Cell Research|January 19, 2008
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastomaIngrid Revet, Gerda Huizenga, Alvin Chan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2007
Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastomaArjen Koppen, Rachida Ait-Aissa, Jan Koster, et al.
International Journal of Cancer|December 5, 2009
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDirk Geerts, Jan Koster, David Albert, et al.
Cancer Research|August 18, 2018
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in NeuroblastomaThomas F Eleveld, Linda Schild, Jan Koster, et al.
Nature Genetics|November 3, 2015
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumorsLinda J Valentijn, Jan Koster, Danny A Zwijnenburg, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2025
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapyElisabeth J M Huijbers, Judy R van Beijnum, Karlijn van Loon, et al.
Iscience|November 24, 2025
Impact of treatment history on drug resistance of metastatic colorectal cancer organoidsMaarten A Huismans, Lidwien P Smabers, Sascha R Brunner, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cancer Letters|October 10, 2009
MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3Ingrid Revet, Gerda Huizenga, Jan Koster, et al.
Journal of Medical Virology|April 9, 2026
Temporal Nasal Epithelial Gene Expression Patterns in Healthy Individuals Infected With Rhinovirus-16, and Its Modulation by Carrot Rhamnogalacturonan-IJasper Mol, Richard Volckmann, Abilash Ravi, et al.
International Journal of Molecular Sciences|April 13, 2023
Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva OsteoclastsTon Schoenmaker, Joy Zwaak, Bruno G Loos, et al.
Experimental Cell Research|January 19, 2008
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastomaIngrid Revet, Gerda Huizenga, Alvin Chan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2007
Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastomaArjen Koppen, Rachida Ait-Aissa, Jan Koster, et al.
International Journal of Cancer|December 5, 2009
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationDirk Geerts, Jan Koster, David Albert, et al.
Cancer Research|August 18, 2018
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in NeuroblastomaThomas F Eleveld, Linda Schild, Jan Koster, et al.
Nature Genetics|November 3, 2015
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumorsLinda J Valentijn, Jan Koster, Danny A Zwijnenburg, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2025
Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapyElisabeth J M Huijbers, Judy R van Beijnum, Karlijn van Loon, et al.
Iscience|November 24, 2025
Impact of treatment history on drug resistance of metastatic colorectal cancer organoidsMaarten A Huismans, Lidwien P Smabers, Sascha R Brunner, et al.
Pageof 4